Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy
AUTOR(ES)
Klein, Fernanda Homem de Mello de Souza, Brenner, Fabiane Mulinari, Sato, Maurício Shigeru, Robert, Fernanda Manfron Batista Rosas, Helmer, Karin Adriane
FONTE
An. Bras. Dermatol.
DATA DE PUBLICAÇÃO
2014-12
RESUMO
BACKGROUND: Masseter hypertrophy has been treated with botulinum toxin injections because of esthetic complaints especially in Asians. OBJECTIVES: The goal of the present study was to evaluate the efficacy of abobotulin toxin use in masseter hipertrophy treatment in Brazilians. METHODS: Ten Brazilian female patients with masseter hypertrophy were subjected to injections of 90U of abobotulinum toxin A applied on each side respecting the safety zone stabilished in literature and were followed up for 24 weeks. RESULTS: When analyzing the coefficients between measures of middle and lower third of the face obtained from standardized photographs, an increase was observed, with statistical significance at 2 weeks (p=0.005) and 12 weeks (p=0.001). The progression of lower third reduction was 3.94%, 5.26%, 11.99%, and 5.47% (2, 4, 12, and 24 weeks respectively). All patients showed improvement in bruxism after treatment. Observed adverse effects were masticatory fatigue, smile limitation, and smile asymmetry. CONCLUSION: The use of abobotulinum toxin A for masseter hypertrophy is effective in Brazilians and reached its maximum effect of facial thinning at 12 weeks. Smile limitation had a higher incidence compared to that reported in the literature and may result from risorius muscle blockage caused by toxin dissemination. Despite its side effects, 80% of the patients would like to repeat the treatment.
Documentos Relacionados
- Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.
- Optimisation of botulinum treatment for cervical and axial dystonias: experience with a Japanese type A toxin.
- Primary treatment of early fistula of parotid duct with botulinum toxin type A injection
- Natural history of treatment of facial dyskinesias with botulinum toxin: a study of 50 consecutive patients over seven years.
- Effect of botulinum toxin type A on the healing of facial skin biopsies - series of cases